No Data
Ito En, Takashow, People (3rd)
※The above Calendar is just a schedule and may be changed due to company circumstances.---------------------------------------March 3 (Monday) <2593> Itoen <7590> Takasho <7865> People---------------------------------------March 4 (Tuesday) <2590> DyDo <3172> Tea Life
Key points of interest in the PTS on the 18th = Fusosha Chemicals, Genepar, and Izu Shabote ETC.
▽ Fuson Chemicals <4368.T> has revised upward its consolidated operating profit Financial Estimates for the fiscal year ending March 2025 from 13.5 billion yen to 16 billion yen (an increase of 44.4% compared to the previous period). Annual Dividends are projected to be 73 yen (previously estimated at 70 yen, with the last year being 66 yen). ▽ Genepa <3195.T> has acquired a patent for filling materials made from a blend of kapok fiber and down feathers, along with the corresponding manufacturing equipment and methods. ▽ Izu Shabote <6819.T> has revised its Dividends forecast and changed its Shareholder benefit program. ▽ Immuno Biological Research <4570>
Software Service: Interim report.
Software Service: Securities Report - 56th Period (2023/11/01 - 2024/10/31)
Key points of interest for the PTS on the 22nd = Demae-can, Info MT, Kobe Bussan.
▽ Demae-can <2484.T>, share buyback ▽ Info MT <2492.T>, revision of the financial estimates for the fiscal year ending December 2024 and announcement of the financial estimates for the fiscal year ending December 2025 ▽ Kobe Bussan <3038.T>, acquisition of a new subsidiary and monthly announcement ▽ T&SG <4055.T>, acquisition of shares in Exstage (subsidiarization) ▽ Renascience <4889.T>, collaboration with the Northwestern University Potocsnak Longevity Institute (Institute for Longevity Research) in the USA at the company's laboratory (Tohoku University Renascience).
BitFuFu Announces Launch of New Software Service